Mayo Clinic
This phase III trial compares the effect of methylene blue mouthwash to standard of care mouthwash for the treatment of oral mucositis pain in patients with cancer. Using methlylene blue mouthwash may improve oral pain in patients with oral mucositis related to cancer and/or cancer treatments compared to usual standard of care.
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Stomatitis
Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse
Methylene Blue Oral Rinse
PHASE3
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 49 participants |
| Masking : | NONE |
| Primary Purpose : | SUPPORTIVE_CARE |
| Official Title : | Methylene Blue Mouthwash for Oral Mucositis Pain in Cancer: An Open-Label, Non-Randomized, Controlled Study |
| Actual Study Start Date : | 2023-06-06 |
| Estimated Primary Completion Date : | 2024-12-06 |
| Estimated Study Completion Date : | 2024-12-06 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905